KẾT QUẢ PHẪU THUẬT NỘI SOI CẮT THỰC QUẢN ĐIỀU TRỊ UNG THƯ THỰC QUẢN TẠI BỆNH VIỆN CHỢ RẪY

Abstract

Esophagectomy is the primary treatment for esophageal cancer. However, it is a highly invasive and technically complex procedure. The complication rate after esophagectomy can be as high as 40%, with a mortality rate of about 1% to 7%. Recently, the application of laparoscopic esophagectomy (LE), especially for the thoracic stage, has brought many advantages, particularly in reducing complications. Laparoscopic esophagectomy has been performed in Vietnam since the early 2000s at major hospitals. At Cho Ray Hospital, LE has been performed since 2003. Since 2016, we have applied neoadjuvant chemotherapy for esophageal cancer treatment in the Department of Gastrointestinal Surgery. We have also performed three-field lymphadenectomy for esophageal cancer since 2017, with promising initial results. We conducted this study to summarize the experience of a single surgeon with laparoscopic esophagectomy for lower thoracic esophageal cancer, from the very beginning of its implementation at our center.